Dyslipidemia in HIV patients

Marisa Tungsiripat, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Judith A. Aberg, MD
Associate Professor of Medicine, Director of HIV, Bellevue Hospital Center, Director of AIDS Clinical Trials Unit, New York University

Address: Marisa Tungsiripat, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Aberg has indicated that she is a consultant for Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, and Glaxo-SmithKline. She received research support from Bristol-Myers Squibb, Abbott, and Merck and is active in the leadership for the National Institute of Allergy and Infectious Diseases-sponsored AIDS Clinical Trials Group.

Marisa Tungsiripat, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Judith A. Aberg, MD
Associate Professor of Medicine, Director of HIV, Bellevue Hospital Center, Director of AIDS Clinical Trials Unit, New York University

Address: Marisa Tungsiripat, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Aberg has indicated that she is a consultant for Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, and Glaxo-SmithKline. She received research support from Bristol-Myers Squibb, Abbott, and Merck and is active in the leadership for the National Institute of Allergy and Infectious Diseases-sponsored AIDS Clinical Trials Group.

Marisa Tungsiripat, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Judith A. Aberg, MD
Associate Professor of Medicine, Director of HIV, Bellevue Hospital Center, Director of AIDS Clinical Trials Unit, New York University

Address: Marisa Tungsiripat, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Aberg has indicated that she is a consultant for Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, and Glaxo-SmithKline. She received research support from Bristol-Myers Squibb, Abbott, and Merck and is active in the leadership for the National Institute of Allergy and Infectious Diseases-sponsored AIDS Clinical Trials Group.